Use App
AI Agent
Trending
News
Earnings
All
DIA
1.87%
SPY
3.64%
QQQ
5.67%
Trending
MRK
0.69%
JNJ
1.25%
CLX
0.16%
ABBV
0.94%
BWET
0.74%
DOGE
0.26%
BTC
5.91%
LNG
0.18%
PZZA
1.14%
ETH
9.12%
Feed
News
Sentiment
Fundamentals
Info
Home
Symbol
EVFM
News
Exchange:
OTC
·
Updated 03:59 PM EST
EVFM News
News
all
press releases
Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt
Aditxt and Evofem file for stockholder approval to finalize their merger in Q4 2024. The acquisition will position Evofem as a wholly owned Aditxt subsidiary, enhancing their women’s health portfolio.
Sponsored
Full Article
1
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile